Advanced Pharma Inc. recalls HEPERAIN 50 mg/50 mL (1mg/mL) Injectable Solution, Heparin Sodium 0.45% Sodium Chloride QS Heparin 50 Units 50 mL,
Advanced Pharma recalls Heparin injectable solution due to label error stating 50 mg/50 mL instead of 50 Units/50 mL. This could lead to incorrect dosing. Check your product's NDC 42852-725-65 and lot 12/19/18 0242 72565S.
Lower-risk recall
Labeling; Label Error on Declared Strength; label incorrectly states the concentration as 50 mg/50 mL (1 mg/mL) rather than the fully accurate concentration as 50 Units/50 mL (1 Unit/mL)
Contact the company & request your remedy
What happened, in plain English
Advanced Pharma is recalling a heparin injectable solution because the label incorrectly states the concentration as 50 mg/50 mL (1 mg/mL) instead of the accurate 50 Units/50 mL (1 Unit/mL). This error could lead to incorrect dosing if the product is used without noticing the mistake. Read more at govinfonow.com/recall/39246-advanced-pharma-heparin-solution-label-error-incorrect-concentration.
Source Summary by GovInfoNow · govinfonow.com/recall/39246-advanced-pharma-heparin-solution-label-error-incorrect-concentration · Updated October 5, 2026 · FDA enforcement record: FDA #D-0430-2019
Cite this page
“Advanced Pharma Heparin Solution Label Error: Incorrect Concentration.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39246-advanced-pharma-heparin-solution-label-error-incorrect-concentration. Based on FDA recall #D-0430-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0430-2019%22&limit=1).
Why it’s dangerous
The label error states the concentration as 50 mg/50 mL instead of the correct 50 Units/50 mL. This could lead to incorrect dosing if the product is used without noticing the mistake, potentially causing treatment issues.
Who’s affected
Patients using heparin injections for medical purposes, particularly those requiring precise dosing. Healthcare providers and patients who have the product with NDC 42852-725-65 and lot 12/19/18 0242 72565S are most at risk.
How to tell if you have this one
Check for the product name 'HEPERAIN 50 mg/50 mL (1mg/mL) Injectable Solution' with NDC 42852-725-65 and lot number 12/19/18 0242 72565S.
- Brand
Advanced Pharma- Category
Drug
What to do — step by step
Check Product Label
Look for the NDC code 42852-725-65 and lot number 12/19/18 0242 72565S on the label.
Questions people ask
Is this product safe to use?
The product is safe to use if the label error is noticed and the correct concentration is used. However, the label error could lead to incorrect dosing if not corrected.
What should I do if I have this product?
Check the product label for NDC 42852-725-65 and lot 12/19/18 0242 72565S. If you have the product, contact Advanced Pharma at (877) 794-0404 for guidance.
How can I confirm if my product is recalled?
Confirm by checking the NDC code 42852-725-65 and lot number 12/19/18 0242 72565S on the product label.
Contact Advanced Pharma
We’ve drafted a message you can send Advanced Pharma to request your refund or repair — edit it as you like.
Subject: Recall D-0430-2019 — Advanced Pharma Advanced Pharma Hello, I own a Advanced Pharma that is covered by recall D-0430-2019 from Advanced Pharma. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0430-2019 (January 15, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0430-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.